Fenofibric acid 45 MG Delayed Release Oral Capsule — RxCUI 828379
RxNorm drug concept · Semantic clinical drug
RxCUI 828379
Semantic clinical drug · SCD
● Current RxNorm concept 20 FDA products
35 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI828379
Official nameFenofibric acid 45 MG Delayed Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped20
Package NDCs mapped35
Reported Medicaid activity (SDUD)7,464 prescriptions · 22 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Fenofibrate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Fenofibrate helps bring your blood lipid levels into a healthier range. Depending on your situation, that might mean lowering your triglycerides, bringing down your LDL (bad) chole...
- What exactly is fenofibrate supposed to do for me?
- It depends on which form you have. Lipofen capsules should be taken with food. Antara capsules and most fenofibrate tablets can be taken with or without food. Some film-coated feno...
- Does it matter if I take this with food or on an empty stomach?
🕸️ Concept Web — How Fenofibric acid 45 MG Delayed Release Oral Capsu... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Fenofibric acid 45 MG Delayed Release Oral Capsule
RxCUI 828379 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Fenofibrate
8703IN -
Fenofibric acid
24852PIN
-
Fenofibrate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Trilipix
828374BN
-
Trilipix
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Fenofibrate Delayed Release Oral Capsule
439656SCDF -
Fenofibric acid Delayed Release Oral Capsule
2645856SCDFP -
Fenofibrate Oral Product
1159042SCDG -
Fenofibrate Pill
1159043SCDG -
Fenofibric acid Oral Product
2659832SCDGP -
Fenofibric acid Pill
2660004SCDGP -
Fenofibrate Delayed Release Oral Capsule [Trilipix]
828376SBDF -
Fenofibric acid Delayed Release Oral Capsule [Trilipix]
2655030SBDFP - +5 more in this family
-
Fenofibrate Delayed Release Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Fenofibric acid 45 MG
828378SCDC -
Fenofibric acid 45 MG Delayed Release Oral Capsule [Trilipix]
828381SBD -
Fenofibric acid 45 MG [Trilipix]
828380SBDC
-
Fenofibric acid 45 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Fenofibric acid 45 MG
SCDC · 828378 -
Fenofibrate Delayed Release Oral Capsule
SCDF · 439656 -
Fenofibric acid Delayed Release Oral Capsule
SCDFP · 2645856 -
Fenofibrate Oral Product
SCDG · 1159042 -
Fenofibrate Pill
SCDG · 1159043 -
Fenofibric acid Oral Product
SCDGP · 2659832 -
Fenofibric acid Pill
SCDGP · 2660004
Brand-Name Concepts
-
Fenofibric acid 45 MG Delayed Release Oral Capsule [Trilipix]
SBD · 828381 -
Fenofibric acid 45 MG [Trilipix]
SBDC · 828380 -
Fenofibrate Delayed Release Oral Capsule [Trilipix]
SBDF · 828376 -
Fenofibric acid Delayed Release Oral Capsule [Trilipix]
SBDFP · 2655030 -
Trilipix Oral Product
SBDG · 1183781 -
Trilipix Pill
SBDG · 1183782 -
Trilipix
BN · 828374
📦 FDA Products & Package NDCs
20 products · 35 package NDCs
35 package NDCs map to RxCUI 828379 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00115-1324-10 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0115-1324-10) | Fenofibric Acid | Amneal Pharmaceuticals of New York LLC | 2024-06-01 |
| 00115-1325-10 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0115-1325-10) | Fenofibric Acid | Amneal Pharmaceuticals of New York LLC | 2024-06-01 |
| 00115-1554-10 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0115-1554-10) | Fenofibric Acid | Amneal Pharmaceuticals of New York LLC | 2016-09-12 |
| 00115-1555-10 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0115-1555-10) | Fenofibric Acid | Amneal Pharmaceuticals of New York LLC | 2016-09-12 |
| 33342-0294-10 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (33342-294-10) | Fenofibric acid | Macleods Pharmaceuticals Limited | 2024-02-26 |
| 33342-0294-12 | 10 BLISTER PACK in 1 CARTON (33342-294-12) / 10 CAPSULE, DE... | Fenofibric acid | Macleods Pharmaceuticals Limited | 2024-02-26 |
| 33342-0295-10 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (33342-295-10) | Fenofibric acid | Macleods Pharmaceuticals Limited | 2024-02-26 |
| 33342-0295-56 | 10 BLISTER PACK in 1 CARTON (33342-295-56) / 14 CAPSULE, DE... | Fenofibric acid | Macleods Pharmaceuticals Limited | 2024-02-26 |
| 42385-0944-11 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42385-944-11) | FENOFIBRIC ACID DELAYED-RELEASE | Laurus Labs Limited | 2020-08-24 |
| 42385-0944-30 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42385-944-30) | FENOFIBRIC ACID DELAYED-RELEASE | Laurus Labs Limited | 2020-08-24 |
| 42385-0944-90 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42385-944-90) | FENOFIBRIC ACID DELAYED-RELEASE | Laurus Labs Limited | 2020-08-24 |
| 42385-0945-11 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42385-945-11) | FENOFIBRIC ACID DELAYED-RELEASE | Laurus Labs Limited | 2020-08-24 |
| 42385-0945-30 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42385-945-30) | FENOFIBRIC ACID DELAYED-RELEASE | Laurus Labs Limited | 2020-08-24 |
| 42385-0945-90 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42385-945-90) | FENOFIBRIC ACID DELAYED-RELEASE | Laurus Labs Limited | 2020-08-24 |
| 42571-0347-30 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42571-347-30) | Fenofibric acid | Micro Labs Limited | 2020-09-01 |
| 42571-0347-90 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42571-347-90) | Fenofibric acid | Micro Labs Limited | 2020-09-01 |
| 42571-0348-05 | 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42571-348-05) | Fenofibric acid | Micro Labs Limited | 2020-09-01 |
| 42571-0348-30 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42571-348-30) | Fenofibric acid | Micro Labs Limited | 2020-09-01 |
| 42571-0348-90 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42571-348-90) | Fenofibric acid | Micro Labs Limited | 2020-09-01 |
| 46708-0244-30 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (46708-244-30) | Fenofibric Acid | Alembic Pharmaceuticals Limited | 2017-05-15 |
| 46708-0244-90 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (46708-244-90) | Fenofibric Acid | Alembic Pharmaceuticals Limited | 2017-05-15 |
| 46708-0244-91 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (46708-244-91) | Fenofibric Acid | Alembic Pharmaceuticals Limited | 2017-05-15 |
| 46708-0245-30 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (46708-245-30) | Fenofibric Acid | Alembic Pharmaceuticals Limited | 2017-05-18 |
| 46708-0245-90 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (46708-245-90) | Fenofibric Acid | Alembic Pharmaceuticals Limited | 2017-05-18 |
| 46708-0245-91 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (46708-245-91) | Fenofibric Acid | Alembic Pharmaceuticals Limited | 2017-05-18 |
| 59651-0216-90 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (59651-216-90) | FENOFIBRIC ACID | Aurobindo Pharma Limited | 2019-07-25 |
| 59651-0217-90 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (59651-217-90) | FENOFIBRIC ACID | Aurobindo Pharma Limited | 2019-07-25 |
| 62332-0244-30 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-244-30) | Fenofibric Acid | Alembic Pharmaceuticals Inc. | 2017-05-15 |
| 62332-0244-90 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-244-90) | Fenofibric Acid | Alembic Pharmaceuticals Inc. | 2017-05-15 |
| 62332-0244-91 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-244-91) | Fenofibric Acid | Alembic Pharmaceuticals Inc. | 2017-05-15 |
| 62332-0245-30 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-245-30) | Fenofibric Acid | Alembic Pharmaceuticals Inc. | 2017-05-15 |
| 62332-0245-90 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-245-90) | Fenofibric Acid | Alembic Pharmaceuticals Inc. | 2017-05-15 |
| 62332-0245-91 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-245-91) | Fenofibric Acid | Alembic Pharmaceuticals Inc. | 2017-05-15 |
| 69315-0281-09 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (69315-281-09) | FENOFIBRIC ACID | Leading Pharma, LLC | 2019-07-18 |
| 69315-0282-09 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (69315-282-09) | FENOFIBRIC ACID | Leading Pharma, LLC | 2019-07-18 |
Observed labelers:
Alembic Pharmaceuticals Inc. (6) ·
Alembic Pharmaceuticals Limited (6) ·
Laurus Labs Limited (6) ·
Micro Labs Limited (5) ·
Amneal Pharmaceuticals of New York LLC (4) ·
Macleods Pharmaceuticals Limited (4)
· +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.